Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia. - Test2 - elhamkhani - TriplyDB

Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia.

Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia.

http://www.wikidata.org/entity/Q30453022

about

Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review Absence of BRINP1 in mice causes increase of hippocampal neurogenesis and behavioral alterations relevant to human psychiatric disorders.Adult neurogenesis and mental illness.Comprehensive Behavioral Analysis of Male Ox1r (-/-) Mice Showed Implication of Orexin Receptor-1 in Mood, Anxiety, and Social Behavior Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and -regulatory protein knockout mice Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response.Synaptosomal-associated protein 25 mutation induces immaturity of the dentate granule cells of adult mice.Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia.An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator.Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia.Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders.Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal nets in gamma-aminobutyric acidergic interneurons of the frontal cortex in adult mice Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus Genomic responses in mouse models greatly mimic human inflammatory diseases.The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice.Comparing Phlebotomy by Tail Tip Amputation, Facial Vein Puncture, and Tail Vein Incision in C57BL/6 Mice by Using Physiologic and Behavioral Metrics of Pain and Distress.Impact of Environmental Enrichment Devices on NTP In Vivo Studies.Immature dentate gyrus: an endophenotype of neuropsychiatric disorders.Quantitative Trait Loci and a Novel Genetic Candidate for Fear Learning.Loss-of-function variants in HIVEP2 are a cause of intellectual disability.In vivo evaluation of cellular activity in αCaMKII heterozygous knockout mice using manganese-enhanced magnetic resonance imaging (MEMRI).Molecular mechanisms and timing of cortical immune activation in schizophrenia.Derivation of neural stem cells from an animal model of psychiatric disease.Elevated viral restriction factor levels in cortical blood vessels in schizophrenia.Rapid and stable changes in maturation-related phenotypes of the adult hippocampal neurons by electroconvulsive treatment.Transcriptomic immaturity of the hippocampus and prefrontal cortex in patients with alcoholism.A starring role for microglia in brain sex differences.Molecular basis of alcoholism.The impact of genetics on future drug discovery in schizophrenia.Adult Neurogenesis and Psychiatric Disorders.Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.Social defeat models in animal science: What we have learned from rodent models.The Effect of Serotonin-Targeting Antidepressants on Neurogenesis and Neuronal Maturation of the Hippocampus Mediated via 5-HT1A and 5-HT4 Receptors.Mutations in HIVEP2 are associated with developmental delay, intellectual disability, and dysmorphic features.Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus.Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus.

P2860

Q27300821-15336A97-A022-4A7C-B190-E9D698920197 Q27310915-492A9BFB-2F45-4D01-A522-EA6D48AF7668 Q28077391-3B9B5714-4A66-42F4-91DB-85A8163872EA Q28505311-05E47435-EE40-4112-9DD0-F43AA5292840 Q30395004-B0278124-A4FD-48EA-B466-E675C360C3FF Q30395479-86832C30-B86A-45F8-A584-F0F72DA9E69F Q30407820-4CA9CD1D-2AB1-4316-AD73-403872D3FBCA Q30447546-26E33B42-F399-433C-BA7A-1A35DCC0378E Q30453712-CAA8321C-CA0C-40E8-BAA3-ADE984D0F529 Q30456114-CBE30A00-DB14-4BF3-A750-64184635EAAD Q30576089-E7142BC3-2082-44C7-8ECB-2C004D65029E Q30842879-C512E37D-E34D-452F-885B-36C55B751CDD Q33789078-3EB264BC-D79D-4881-9350-30467F6C22AC Q34356542-92C45120-63DF-44D9-991C-AF49088124D3 Q34428194-7CC6C640-703F-4D54-BE76-CFEDC9C5E766 Q34479521-160FA529-C541-41F6-895D-D3F902E544F3 Q34955777-6F7C68FF-2356-457C-9F3A-8A67CCF63FB6 Q35037958-B1F26DD6-5B1C-49EF-81DF-C2D033FA3EB3 Q35881717-FAE5B30C-11D1-49A2-B012-0625D9663BA4 Q36378836-75D1962B-D35A-4463-A151-3CE0E5EF900B Q36669650-652DEBE8-A487-4A19-B2E6-BB97DD18D274 Q36960113-1ED1F6D6-DCA0-4CA8-8B0D-AD58B8263DBC Q36985357-B1F458AC-0A2F-49E5-828C-E7AAEE1E1A62 Q37058019-C5A390AB-EA0C-4D25-88D1-3E0925B9A372 Q37293215-1F8A9FFA-E6CF-47CA-97CE-0B2A77EEF2C9 Q37337567-D680DF53-BE08-487E-BF47-0841534C9A3B Q37362348-CA472230-DE35-4C1F-9C23-76D4D16F33DA Q37672679-2BB20DF4-EC11-4618-AD27-27308DB28F39 Q37679181-E93D8F1A-DBB3-474F-89FE-0879A579BA8A Q37704784-2CC46C4A-B8C5-45B3-AA1E-E8B2EF02C317 Q38215667-0DC14BD1-B5F9-4F5F-9AB4-A19EFF2AA446 Q38259368-E8D5943E-65DE-48F0-B990-4B1BD28DB251 Q38682213-E0E8B37E-8EB5-4784-A776-F33B1E466CE1 Q38708466-EEE9FFD8-7E3E-4A3B-A125-FD336E7772C1 Q39050960-37BA9F53-9E0B-42B8-8A36-0EE0D57DAFB1 Q39258097-933F0EB0-C70A-40D2-9150-61CFC025BAC6 Q39339323-176BFF87-AE5B-4BD2-9E2F-5EB88EEB5C9C Q40839030-206CFCA1-AEEE-4302-AD83-6A221AF119EC Q40942272-41496BEA-3C11-432E-BA99-96A6882A1F2A Q41838987-C8173BC5-AB4D-47F4-9B05-D1271495A3B9

P2860

Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain and confers molecular, neuronal, and behavioral phenotypes related to schizophrenia.

http://www.wikidata.org/entity/Q30453022

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@ast

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@en

type

label

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@ast

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@en

prefLabel

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@ast

Deficiency of schnurri-2, an M ...... ypes related to schizophrenia.

@en

P1433

Q30453022-11FB6DAF-B366-47C3-AD37-537BFDCA7202

P1476

Q30453022-F9BD37AF-E0E0-41D7-AB8B-B4BED0967F3A

P2093

Q30453022-06C24497-D305-423A-A2A5-D7FDE1EB80E4

Q30453022-0A5E95EB-5367-4B88-9B96-48CC924A1CB8

Q30453022-0F817988-9542-45F2-A423-66E295D55A08

Q30453022-0FFEE14E-C9A0-468E-8D77-61882FA5DAF2

Q30453022-12C5B7A7-A136-4C2A-AFE2-359606A8E45E

Q30453022-141BA224-B585-4CC7-A041-EB5AFC28325B

Q30453022-17E2DFCB-FD5C-455E-BB5E-77B013060789

Q30453022-30297803-9056-4EC5-A4B8-20B249EA2FAC

Q30453022-475A1E83-0C10-4C81-85EA-34A7643878D2

Q30453022-56DBC33F-C35B-4847-A4AC-D9FA5BB52334

P2860

Q30453022-025DAC96-1B4E-4EA6-8287-5EE85F8EC0E6

Q30453022-02E7ACE6-20C0-4F00-96D0-D4A3E64962FA

Q30453022-083D7C26-A18C-45C1-8343-EEBF4ECA26CB

Q30453022-12BB086C-EEB0-4792-98A2-D056294DFE13

Q30453022-1EA194BF-5C80-4D77-92D3-D6B01DF229E1

Q30453022-2016D76A-AEA2-4E6C-B14F-2069105DE06F

Q30453022-21FB7070-8F25-42F1-AC68-A72B4F54C430

Q30453022-2592442F-2566-4514-8BB6-1A9A86A788E9

Q30453022-2B2560D8-D5CB-4DB2-B0B6-8220043AD6F8

Q30453022-2E149C76-30D1-408B-AAA7-3B44FCA10FEE

P2888

Q30453022-C9E75B12-5ECE-437C-8734-1F0138F2356F

P304

Q30453022-7A55AF72-D837-485C-A9C9-7D503C5C2820

P31

Q30453022-47FB503C-5FE3-4EA3-A61E-27988990A5E1

P356

Q30453022-AEBA787F-AF12-4E8D-9C06-C67345AC4CE7

P407

Q30453022-B3D7A744-917A-4E57-8F5F-D32DD2D5539B

P433

Q30453022-2291805E-90FB-4932-8D84-97A08C806362

P478

Q30453022-13F7A429-C3E6-4B1C-BC4C-40982846DE77

P50

Q30453022-18370FD7-E8F0-4C70-AC13-0C65E6656337

Q30453022-26F7BAF0-21BE-4447-8852-36462353668B

Q30453022-2B2EF879-5DCE-47D3-9942-9F2B0E7E9164

Q30453022-686B9415-AEE4-4CB2-8A4C-FA9FDEBBA640

Q30453022-7165A1EA-BDD7-4F88-BDD8-89447CCF58F5

Q30453022-9A5E9BF4-0079-4251-913F-AE7E5F59C379

Q30453022-BFBF0141-91EF-4EF1-8DF6-BAB19BFF0A83

Q30453022-FAF53658-3675-4AFA-A01B-BEAFE7ACA28D

P577

Q30453022-895D035B-F82C-41DE-92A6-A47D3AFE2D50

P5875

Q30453022-9FE75F96-113E-4D0D-9E44-CD3DB541674F

P6179

Q30453022-58F5CEAF-D7DB-419C-BA12-4BABB3B7DE76

P698

Q30453022-A675F067-FB10-488F-9C96-154552B622FA

P921

Q30453022-526F1A19-0E53-4D07-B1AF-921D504E4EE8

Q30453022-C6DFDA63-E4F9-45FA-8A95-A35FF6FBD71E

P932

Q30453022-B08D5E71-9CF0-4660-A3D1-1AFC7AD70FF7

P356

P1433

Neuropsychopharmacology

P1476

Deficiency of schnurri-2, an M ...... types related to schizophrenia

@en

P2093

Akinori Nishi

http://www.w3.org/2001/XMLSchema#string

Hidenori Suzuki

http://www.w3.org/2001/XMLSchema#string

Hironori K Nakamura

http://www.w3.org/2001/XMLSchema#string

Hirotaka Shoji

http://www.w3.org/2001/XMLSchema#string

Jun Maeda

http://www.w3.org/2001/XMLSchema#string

Kayoko Esaki

http://www.w3.org/2001/XMLSchema#string

Keiko Toyama

http://www.w3.org/2001/XMLSchema#string

Kimie Atsuzawa

http://www.w3.org/2001/XMLSchema#string

Mahomi Kuroiwa

http://www.w3.org/2001/XMLSchema#string

Makoto Higuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Common variants conferring risk of schizophrenia

Common variants on chromosome 6p22.1 are associated with schizophrenia

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

Theta rhythms coordinate hippocampal-prefrontal interactions in a spatial memory task

IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase

Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function

Inverse synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1 with CaMKIIβ

P2888

P304

1409-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2013.38

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Tsuyoshi Miyakawa

Hisatsugu Koshimizu

Katsunori Kobayashi

P577

2013-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235416112

http://www.w3.org/2001/XMLSchema#string

P6179

1036436531

http://www.w3.org/2001/XMLSchema#string

P698

23389689

http://www.w3.org/2001/XMLSchema#string

P921

P932

3682135

http://www.w3.org/2001/XMLSchema#string